A Strategy for Designing Voriconazole Dosage Regimens to Prevent Invasive Pulmonary Aspergillosis Based on a Cellular Pharmacokinetics/Pharmacodynamics Model

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-018-1533-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effect of PTX3 and Voriconazole Combination in a Rat Model of Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Efficacy and Pharmacodynamics of Flucytosine Monotherapy in a Nonneutropenic Murine Model of Invasive Aspergillosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

A Case of Chronic Necrotizing Pulmonary Aspergillosis Treated With Voriconazole

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2009English

ADAMTS13 Regulates Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Efficacy of Ambruticin Analogs in a Murine Model of Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Effect of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Zolpidem in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2007English

CT of Invasive Pulmonary Aspergillosis

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1988English

Standardization of an Experimental Murine Model of Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Pharmacokinetics and Pharmacodynamics of Two Multiple-Dose Piperacillin-Tazobactam Regimens.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy